B cells and tertiary lymphoid structures promote immunotherapy response

2020/01/15 by Beth A. Helmink, Sangeetha M. Reddy, Jianjun Gao +67 · 31 citations
Medicine · Immunology and Microbiology · #Cancer Immunotherapy and Biomarkers #Immune Cell Function and Interaction #CAR-T cell therapy research

paper · doi:10.1038/s41586-019-1922-8

Citations

• Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types
• B cells are associated with survival and immunotherapy response in sarcoma

Cited by

• B cells are associated with survival and immunotherapy response in sarcoma
• Humoral determinants of checkpoint immunotherapy
• Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology
• The diversity of CD8+ T cell dysfunction in cancer and viral infection
• Sustained innate interferon is an essential inducer of tertiary lymphoid structures
• B cells in non-lymphoid tissues
• Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma
• Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structures
• A RAS(ON) Multi-Selective Inhibitor Combination Therapy Triggers Long-term Tumor Control through Senescence-Associated Tumor-Immune Equilibrium in Pancreatic Ductal Adenocarcinoma
• Boosting human immunology: harnessing the potential of immune organoids
• Functional and molecular characterization of PD1+ tumor-infiltrating lymphocytes from lung cancer patients.
• Tertiary Lymphoid Structures Across Organs: Context, Composition, and Clinical Levers
• Mature Tertiary Lymphoid Structures in Breast Cancers Are Associated With Antitumor Immunity and Better Prognosis
• Dendritic cells type 1 control the formation, maintenance, and function of tertiary lymphoid structures in cancer
• Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers
• High endothelial venules (HEVs) in immunity, inflammation and cancer
• T cells in health and disease
• The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology
• S1PR1 regulates lymphatic valve development and tertiary lymphoid organ formation in the ileum
• Immunovascular classification of HCC reflects reciprocal interaction between immune and angiogenic tumor microenvironments
• PD-1–targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancer
• A SITC vision: adapting clinical trials to accelerate drug development in cancer immunotherapy
• Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial
• Spatial resolved transcriptomics: Computational insights into gene transcription across tissue and organ architecture in diverse applications
• Newly Identified Transcriptomic Biomarkers and Gene Signature of Pathological Complete Response to Induction Chemoimmunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
• Selective tubulin-binding drugs induce pericyte phenotype switching and anti-cancer immunity
• A novel dataset for nuclei and tissue segmentation in melanoma with baseline nuclei segmentation and tissue segmentation benchmarks
• Targeting angiogenesis: Lessons from 25 years of normalizing tumor vasculature
• Peripheral Nerves in Cancer: Regulatory Roles and Therapeutic Strategies
• Molecular Mechanisms Governing CD8 T Cell Differentiation and Checkpoint Inhibitor Response in Cancer
• Regulators of CD8+ T cell exhaustion